Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
On Match Day, ApolloMD opens its $5,000 Emergency Medicine Scholarship, supporting future clinician leaders in emergency medicine. Apply by June 15.
-
SOMERSET, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions, today announced...
-
Machina Medical received FDA 510(k) clearance for MFUSE, a single-use device providing rapid, temporary external control of moderate to severe bleeding.
-
ApolloMD Announces Leadership Appointments to Strengthen Hospital Operations and Revenue Performance
ApolloMD announced leadership appointments strengthening hospital operations, revenue cycle performance, and long-term partnership stability.
-
Dublin, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The "United States Fair-Market Value Compensation Rates for Emergency Medicine KOLs" report has been added to ResearchAndMarkets.com's offering.This report...
-
VANCOUVER, B.C., May 23, 2025 (GLOBE NEWSWIRE) -- ScribeCanada, a care team support solutions provider, is excited to announce its participation in two leading healthcare conferences this spring. ...
-
PLEASANTON, CA, March 29, 2025 (GLOBE NEWSWIRE) -- SFJ Pharmaceuticals (SFJ) and SERB Pharmaceuticals (SERB) announced today the final results of the pivotal Phase 3 REVERSE-IT trial designed to...
-
San Antonio, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Velico Inc. launched a groundbreaking collaboration with South Texas Blood & Tissue (STB&T), a subsidiary of San Antonio-based nonprofit...
-
Selbyville, Delaware, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Acute care telemedicine market size was valued at USD 26.7 billion in 2024 and is projected to grow at a CAGR of 14.9% from 2025 to 2034....
-
Philadelphia, PA, Oct. 21, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the acquisition of Aurlumyn™ (iloprost IV), the only FDA approved...